Alpha1 antitrypsin deficiency is a genetic disorder. Alpha1 antitrypsin deficiency is hereditary. Alpha1 antitrypsin deficiency is the most common genetic cause of liver disease in children. Alpha1 antitrypsin deficiency is historically linked to liver disease.
Liver disease in those with Alpha1 antitrypsin deficiency can present liver cancer in approximately 15% to 25% of those with Alpha1 antitrypsin deficiency. Alpha1 antitrypsin deficiency has been found to cause lung disease in those at low levels of circulating Alpha1 Antitrypsin.
With alpha1 antitrypsin deficiency, the liver does not circulate enough viably active alpha1 antitrypsin into the circulatory system to protect individuals from various diseases. This can be from improperly unfolding Alpha1 or the liver not producing the protein in adequate volumes to protect the body.
Our research will show that the incidence of this condition is much greater than the medical community is aware of as of the filing of our research work to the US Patent Office in 2020.